Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Ahmad, M, Catto, J, Azzouzi, A, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F, Rehman, I
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2003

Ижил төстэй зүйлс

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
-н: Rehman, I, зэрэг
Хэвлэсэн: (2004)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
-н: Rehman, I, зэрэг
Хэвлэсэн: (2004)

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine
-н: Rehman, I, зэрэг
Хэвлэсэн: (2005)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
-н: Yates, DR, зэрэг
Хэвлэсэн: (2006)

Genetic instability and transitional cell carcinoma of the bladder.
-н: Catto, J, зэрэг
Хэвлэсэн: (2004)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
-н: Rehman, I, зэрэг
Хэвлэсэн: (2003)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
-н: Catto, J, зэрэг
Хэвлэсэн: (2005)

Promoter hypermethylation identifies progression risk in bladder cancer.
-н: Yates, DR, зэрэг
Хэвлэсэн: (2007)

The use of proteomics in urological research
-н: Rehman, I, зэрэг
Хэвлэсэн: (2005)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
-н: Yates, DR, зэрэг
Хэвлэсэн: (2006)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
-н: Yates, DR, зэрэг
Хэвлэсэн: (2005)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
-н: van Oers, J, зэрэг
Хэвлэсэн: (2009)

Clinically localised prostate cancer is microsatellite stable.
-н: Azzouzi, A, зэрэг
Хэвлэсэн: (2007)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
-н: Catto, J, зэрэг
Хэвлэсэн: (2003)

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation
-н: Cross, S, зэрэг
Хэвлэсэн: (2005)

A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis
-н: Carolien M. Woolthuis, зэрэг
Хэвлэсэн: (2013-10-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
-н: Rehman, I, зэрэг
Хэвлэсэн: (2008)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
-н: Glen, A, зэрэг
Хэвлэсэн: (2008)

Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23.
-н: Takemura, M, зэрэг
Хэвлэсэн: (2002)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
-н: Dhawan, D, зэрэг
Хэвлэсэн: (2006)

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids
-н: Patricia M. Day, зэрэг
Хэвлэсэн: (2015-12-01)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
-н: Catto, J, зэрэг
Хэвлэсэн: (2007)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
-н: Yates, D, зэрэг
Хэвлэсэн: (2005)

Urinary Bladder Xanthoma – Is Immunohistochemistry Necessary?
-н: M. Raghavendran, зэрэг
Хэвлэсэн: (2016-09-01)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
-н: Catto, J, зэрэг
Хэвлэсэн: (2006)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
-н: Catto, J, зэрэг
Хэвлэсэн: (2003)

Prostate cancer proteomics: The urgent need for clinically validated biomarkers
-н: Evans, C, зэрэг
Хэвлэсэн: (2009)

Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme
-н: Spencer, A, зэрэг
Хэвлэсэн: (2004)

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
-н: Catto, J, зэрэг
Хэвлэсэн: (2003)

Nucleophosmin 1 expression in acute myeloid leukemia
-н: Mohammad Davoudi, зэрэг
Хэвлэсэн: (2015-10-01)

Nucleophosmin 1 expression in acute myeloid leukemia
-н: Mohammad Davoudi, зэрэг
Хэвлэсэн: (2015-09-01)

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
-н: Rehman, I, зэрэг
Хэвлэсэн: (2005)

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
-н: Catto, J, зэрэг
Хэвлэсэн: (2006)

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
-н: Markéta Šašinková, зэрэг
Хэвлэсэн: (2021-01-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
-н: Roupret, M, зэрэг
Хэвлэсэн: (2004)

Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation
-н: Duangmano Suwit, зэрэг
Хэвлэсэн: (2012-10-01)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
-н: Rouprêt, M, зэрэг
Хэвлэсэн: (2005)

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
-н: Rehman, I, зэрэг
Хэвлэсэн: (2004)

Targeting chemotherapy to advanced bladder cancer patients most likely to benefit.
-н: Catto, J, зэрэг
Хэвлэсэн: (2010)

Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
-н: Grzegorz Sarek, зэрэг
Хэвлэсэн: (2010-03-01)